ArticleTrials2022

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].

Xuan Ying Poh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.